These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 596368)

  • 21. THE ACTION OF TWO SULFHYDRYL COMPOUNDS ON NORMAL HUMAN RED CELLS. RELATIONSHIP TO RED CELLS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.
    SIRCHIA G; FERRONE S; MERCURIALI F
    Blood; 1965 Apr; 25():502-10. PubMed ID: 14284339
    [No Abstract]   [Full Text] [Related]  

  • 22. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
    J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.
    Rosse WF; Logue GL; Adams J; Crookston JH
    J Clin Invest; 1974 Jan; 53(1):31-43. PubMed ID: 4855546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes.
    Sica M; Rondelli T; Ricci P; De Angioletti M; Risitano AM; Notaro R
    J Hematol Oncol; 2017 Jun; 10(1):126. PubMed ID: 28629435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of in vitro lysis of paroxysmal nocturnal haemoglobinuria (PNH) and PNH-like red cells.
    Ferrone S; Marubini E; Mercuriali F; Sirchia G
    Br J Haematol; 1972 Jul; 23(1):5-12. PubMed ID: 5045962
    [No Abstract]   [Full Text] [Related]  

  • 26. Erythrocyte vesiculation in paroxysmal nocturnal hemoglobinuria.
    Pan H; Ji Z; Liu E; Zhang Z
    Chin Med Sci J; 1991 Jun; 6(2):84-6. PubMed ID: 1725134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of paroxysmal nocturnal hemoglobinuria to other pH-dependent hemolytic systems: role of acetylcholinesterase.
    Laforet MT; Gardner FH
    Acta Haematol; 1967; 37(2):88-93. PubMed ID: 4961919
    [No Abstract]   [Full Text] [Related]  

  • 28. Activation of complement by stroma from normal and paroxysmal nocturnal haemoglobinuria red cells.
    De Sandre G; Corrocher R; Falezza GC; Aprili G; Caffi S
    Scand J Haematol; 1978 Mar; 20(3):265-70. PubMed ID: 644255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysis of red blood cells in some haemolytic anaemias--the lytic effect of agkistrodon piscivorus venom in vitro.
    Brabec V; Kornalík F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(3):428-35. PubMed ID: 72030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the enhanced susceptibility of paroxysmal nocturnal hemoglobinuria erythrocytes to complement-mediated hemolysis initiated by cobra venom factor.
    Parker CJ; Stone OL; Bernshaw NJ
    J Immunol; 1989 Jan; 142(1):208-16. PubMed ID: 2909615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relation between the complement sensitive red cells and the frequency of exacerbation of hemoglobinuria in paroxysmal nocturnal hemoglobinuria].
    Shichishima T; Uchida T; Kariyone S; Terasawa T
    Nihon Naika Gakkai Zasshi; 1987 Aug; 76(8):1224-9. PubMed ID: 3681094
    [No Abstract]   [Full Text] [Related]  

  • 33. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.
    Holguin MH; Wilcox LA; Bernshaw NJ; Rosse WF; Parker CJ
    J Clin Invest; 1989 Nov; 84(5):1387-94. PubMed ID: 2478585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of the alternative pathway of complement by pH.
    Fishelson Z; Horstmann RD; Müller-Eberhard HJ
    J Immunol; 1987 May; 138(10):3392-5. PubMed ID: 2952717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of horseshoe crab blood lectin on complement mediated hemolysis of paroxysmal nocturnal hemoglobinuria-like erythrocytes].
    Wang KY; Li SY; Pan HZ; Li CH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Feb; 6(1):62-4. PubMed ID: 6238702
    [No Abstract]   [Full Text] [Related]  

  • 36. Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients.
    Schmidt CQ; Harder MJ; Nichols EM; Hebecker M; Anliker M; Höchsmann B; Simmet T; Csincsi ÁI; Uzonyi B; Pappworth IY; Ricklin D; Lambris JD; Schrezenmeier H; Józsi M; Marchbank KJ
    Immunobiology; 2016 Apr; 221(4):503-11. PubMed ID: 26792457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ascorbic acid-induced hemolysis of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Iwamoto N; Nakakuma H; Ota N; Shimokado H; Takatsuki K
    Am J Hematol; 1994 Dec; 47(4):337-8. PubMed ID: 7977314
    [No Abstract]   [Full Text] [Related]  

  • 38. Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor.
    Medof ME; Kinoshita T; Silber R; Nussenzweig V
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2980-4. PubMed ID: 2581259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-lymphocytes escape membrane defect in paroxysmal nocturnal haemoglobinuria.
    Cooper MR; Currie MS; Rustagi PK; Logue GL
    Br J Haematol; 1983 Oct; 55(2):263-71. PubMed ID: 6604541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paroxysmal nocturnal hemoglobinuria. Alternate-complement-pathway-mediated lysis induced by magnesium.
    May JE; Rosse W; Frank MM
    N Engl J Med; 1973 Oct; 289(14):705-9. PubMed ID: 4727529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.